The US Food and Drug Administration (FDA) said on Monday that it has approved Zovirax Cream 5% (acyclovir) for the treatment of recurrent herpes labialis, or cold sores, in patients over the age of 12. Biovail Corp. has US marketing rights to the GlaxoSmithKline product.
The companies announced late last week that they had expanded their agreement on the drug, which also covers Zovirax ointment, an already-marketed treatment for genital herpes.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!